Linus cyclopeptide 9 contains a constrained cyclic topology that promotes conformational rigidity and resistance to unfolding. Aromatic and hydrophobic residues shape its interaction profile. Researchers study its binding specificity and structural transitions. Uses include cyclic-peptide engineering, structural biology, and natural-product analog development.
CAT No: R2682
CAS No:33302-55-5
Synonyms/Alias:Linus cyclopeptide 9;33302-55-5;cyclolinopeptide A;(9S,12S,15S,18S,21S,24S,27S,30S)-24,27-Dibenzyl-15-[(2S)-butan-2-yl]-9,12,21-tris(2-methylpropyl)-18-propan-2-yl-1,7,10,13,16,19,22,25,28-nonazatricyclo[28.3.0.03,7]tritriacontane-2,8,11,14,17,20,23,26,29-nonone;
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More